OBJECTIVES: To determine risk factors for poor outcomes among patients with pulmonary multidrug- or extensively drug-resistant (M/XDR) tuberculosis (TB) in Georgia. METHODS: This was a prospective, population-based observational cohort study. RESULTS: Among 380M/XDR-TB patients (mean age 38 years), 179 (47%) had a poor outcome: 59 (16%) died, 37 (10%) failed, and 83 (22%) defaulted. Newly diagnosed M/XDR-TB cases were significantly more likely to have a favorable outcome than retreatment cases (odds ratio (OR) 4.26, 95% confidence interval (CI) 1.99-9.10, p<0.001). In the multivariable analysis, independent risk factors for a poor treatment outcome included previous treatment history (OR 2.92, 95% CI 1.29-6.58), bilateral disease (OR 1.90, 95% CI 1.20-3.01), body mass index (BMI, kg/m(2)) ≤18.5 (OR 1.91, 95% CI 1.11-3.29), and XDR-TB (OR 2.28, 95% CI 1.11-4.71). Patients who underwent surgical resection (OR 0.27, 95% CI 0.11-0.64) and had sputum culture conversion by 4 months (OR 0.33, 95% CI 0.21-0.52) were significantly less likely to have poor treatment outcomes. CONCLUSIONS: Adjunctive surgery appeared to be beneficial in treating patients with M/XDR-TB. Retreatment cases, XDR-TB, bilateral disease, and low BMI were associated with a poor outcome. Additional studies are needed to further define the apparent beneficial role of surgery in the treatment of M/XDR-TB.
OBJECTIVES: To determine risk factors for poor outcomes among patients with pulmonary multidrug- or extensively drug-resistant (M/XDR) tuberculosis (TB) in Georgia. METHODS: This was a prospective, population-based observational cohort study. RESULTS: Among 380M/XDR-TBpatients (mean age 38 years), 179 (47%) had a poor outcome: 59 (16%) died, 37 (10%) failed, and 83 (22%) defaulted. Newly diagnosed M/XDR-TB cases were significantly more likely to have a favorable outcome than retreatment cases (odds ratio (OR) 4.26, 95% confidence interval (CI) 1.99-9.10, p<0.001). In the multivariable analysis, independent risk factors for a poor treatment outcome included previous treatment history (OR 2.92, 95% CI 1.29-6.58), bilateral disease (OR 1.90, 95% CI 1.20-3.01), body mass index (BMI, kg/m(2)) ≤18.5 (OR 1.91, 95% CI 1.11-3.29), and XDR-TB (OR 2.28, 95% CI 1.11-4.71). Patients who underwent surgical resection (OR 0.27, 95% CI 0.11-0.64) and had sputum culture conversion by 4 months (OR 0.33, 95% CI 0.21-0.52) were significantly less likely to have poor treatment outcomes. CONCLUSIONS: Adjunctive surgery appeared to be beneficial in treating patients with M/XDR-TB. Retreatment cases, XDR-TB, bilateral disease, and low BMI were associated with a poor outcome. Additional studies are needed to further define the apparent beneficial role of surgery in the treatment of M/XDR-TB.
Authors: Neel R Gandhi; Paul Nunn; Keertan Dheda; H Simon Schaaf; Matteo Zignol; Dick van Soolingen; Paul Jensen; Jaime Bayona Journal: Lancet Date: 2010-05-22 Impact factor: 79.321
Authors: Timothy H Holtz; Maya Sternberg; Steve Kammerer; Kayla F Laserson; Vija Riekstina; Evija Zarovska; Vija Skripconoka; Charles D Wells; Vaira Leimane Journal: Ann Intern Med Date: 2006-05-02 Impact factor: 25.391
Authors: D S Jeon; D H Kim; H S Kang; S H Hwang; J H Min; J H Kim; N M Sung; M W Carroll; S K Park Journal: Int J Tuberc Lung Dis Date: 2009-05 Impact factor: 2.373
Authors: N Lomtadze; R Aspindzelashvili; M Janjgava; V Mirtskhulava; A Wright; H M Blumberg; A Salakaia Journal: Int J Tuberc Lung Dis Date: 2009-01 Impact factor: 2.373
Authors: D J Palmero; M Ambroggi; A Brea; M De Lucas; A Fulgenzi; D Martínez; C Mosca; R Musella; M Natiello; C Gonzalez; E Abbate Journal: Int J Tuberc Lung Dis Date: 2004-06 Impact factor: 2.373
Authors: Evan W Orenstein; Sanjay Basu; N Sarita Shah; Jason R Andrews; Gerald H Friedland; Anthony P Moll; Neel R Gandhi; Alison P Galvani Journal: Lancet Infect Dis Date: 2009-03 Impact factor: 25.071
Authors: Russell R Kempker; Nestani Tukvadze; Lisa Sthreshley; Lisa Sharling; Dawn L Comeau; Matthew J Magee; Carlos Del Rio; Zaza Avaliani; Henry M Blumberg Journal: Am J Trop Med Hyg Date: 2018-02-01 Impact factor: 2.345
Authors: Maia Kipiani; Veriko Mirtskhulava; Nestani Tukvadze; Matthew Magee; Henry M Blumberg; Russell R Kempker Journal: Clin Infect Dis Date: 2014-08-04 Impact factor: 9.079
Authors: Russell R Kempker; Maia Kipiani; Veriko Mirtskhulava; Nestani Tukvadze; Matthew J Magee; Henry M Blumberg Journal: Emerg Infect Dis Date: 2015-06 Impact factor: 6.883
Authors: Sergo A Vashakidze; Shota G Gogishvili; Ketino G Nikolaishvili; Zaza R Avaliani; Abivarma Chandrakumaran; Giorgi Sh Gogishvili; Mathew Magee; Henry M Blumberg; Russell R Kempker Journal: Eur J Cardiothorac Surg Date: 2021-12-01 Impact factor: 4.534
Authors: Rebecca C Harris; Mishal S Khan; Laura J Martin; Victoria Allen; David A J Moore; Katherine Fielding; Louis Grandjean Journal: BMC Infect Dis Date: 2016-06-10 Impact factor: 3.090